Results 281 to 290 of about 145,091 (327)
This study reports a 2‐day‐old neonate whose echocardiographic features are consistent with LVNC. The patient exhibited severe metabolic abnormalities and experienced recurrent heart failure episodes temporally associated with these metabolic derangements.
Jinqiu Huang, Ziyue Zhang, Juxian Yang
wiley +1 more source
Cardiac Rehabilitation in Advanced Dilated Cardiomyopathy Within a Resource-Limited Setting. [PDF]
Hernández-Gutiérrez KG +7 more
europepmc +1 more source
Association of P‐Wave Parameters With Left Atrial Hemodynamics in Atrial Cardiomyopathy
In the present study, the validity of seven established P‐wave parameters in relation to left atrial hemodynamics was investigated. Our study suggests that advanced IAB is the strongest indicator of altered left atrial hemodynamics and, thus, AtCM.
Melissa Kazantzi +10 more
wiley +1 more source
Late Gadolinium Enhancement Variation in Asymptomatic Individuals: Comparison with Dilated Cardiomyopathy. [PDF]
Park S, Cho SJ, Kim SM, Kim MY, Choe YH.
europepmc +1 more source
Red blood cell endothelial nitric oxide synthase: A major player in regulating cardiovascular health
Abstract Red blood cells (RBCs) have traditionally been seen as simple carriers of gases and nutrients in the body. One important non‐canonical function of RBCs in the cardiovascular system is the regulation of nitric oxide (NO) metabolism. It has been shown that RBCs can scavenge NO, transport NO metabolites and produce NO in hypoxic conditions ...
Anthea LoBue +7 more
wiley +1 more source
Role of NPPB for recovery post ventricular assist device in paediatric dilated cardiomyopathy: Single-cell multiomics. [PDF]
Kugo Y +7 more
europepmc +1 more source
Interest of Cardiac MRI in the Etiological Diagnosis of Dilated Cardiomyopathies: About 45 Cases
LOUDIYI, Nadia +5 more
openalex +1 more source
Eplerenone improves kidney function and cardiac performance in obese male mice
Abstract Aims Renin‐angiotensin‐aldosterone system (RAAS) activation mediates obesity‐associated cardiorenal dysfunction. Due to an incomplete understanding of the molecular mechanisms, the clinical use of RAAS antagonism in obesity‐associated cardiometabolic complications remains uncertain.
Ayman K. Banah +8 more
wiley +1 more source

